Cyclogest Pessaries 400 mg

Country: Jordan

Language: English

Source: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Active ingredient:

Progesterone 400 mg

Available from:

مستودع أدوية بيتا - Beta Drug Store

ATC code:

G03DA04

INN (International Name):

Progesterone 400 mg

Dosage:

400 mg

Units in package:

15

Manufactured by:

Accord UK Ltd/UK (بريطانيا)

Product summary:

13.23 :سعر الجمهور + الضريبة

Patient Information leaflet

CYCLOGEST'
ilililffi1
Product
lnformation
lnsert
8.'l
Company's
name:
8,2
Actavis,
Barnstaple,
EX32
8N5, UK
1.
ldentification
1.1
Trade name:
CYCLOGEST@
1,2
Generk
name:
Progesterone.
2./3.
Form
and strengths:
Pessaries
each
containing
200m9
and
400m9
progesterone.
4.
Pharmaco-therapeutic
group:
Progesterone
is
a
progestational
steroid.
5.
The
name
and
address
ofthe
manufacturing
authorisation
holder
Actavis,
Barnstaple,
EX32
8N5,
UK
6.
Therapeutic
indications
1)
Treatment
of
premenstrual
syndrome, including
premenstrual
tension
and depression.
2)
Treatment
of
puerperal
depression.
7.
Active
and inactive
ingredients
and
their
quantities
8'3
Each
pessary
contains
as
active
ingredient
200mg
and
400mg
9'
progesterone.
'
9'1
lnactive ingredient:
Vegetable fat.
8.
A
list
of information
200
ffig,400
mg
Pessaries
Cyclogest
is
a
trademark
of
L.D.
Collins
& Co.
Ltd
Registered
in
the
UK
and other
jurisdictions.
ililililil1
Contra-indications
Undiagnosed
vaginal
bleeding.
Precautions
Use
vaginally
if
patients
suffer
from
colitis
or faecal
incontinence.
Use
rectally
if
patients
suffer
from vaginal
infection
(especially
moniliasis)
or
recuJrerrt
Ey,stitis.
Use
rectally
in
patients
who
have
recently
given
birth.
Use
rectally
if
barrier methods
of
contraception
are used.
Progesterone
is
metabolised
in
the
Iiver
and should
be used
with
caution in
patients
with
hepatic
dysfunction.
Cyclogest
contains
the hormone
progesterone
which
is
present
in
significant concentrations
in
women
during the
second half
of
the
menstrual
cycle
and during
pregnancy.This
should
be
borne
in mind
when treating
patients
with
conditions
that
may
be
hormone-sensitive.
Drug and
food interactions
None
known.
Special
warnings
ln
children
Not applicable.
9.3
9.4
9.5
Y.2
9.8
501
02486
rn
Pregnanr
women
Due
to the indications
of
the
product,
unless advised by
the
treating
physician,
it
is
anticipated
that
it
will
not
be
administered
to
pregnant
women.
As
progesterone
is
a
natural hormone,
it
is
not
expected
to
have adverse effects,
however, no evidence
is
avail